SCHEMBL13459936

SCHEMBL13459936

N#Cc1nccc2c(-c3ccc(NC(=O)Nc4cccc(Oc5ccccc5)c4)cc3)cccc12

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FLT1 P17948 1/20 0.51
▸ TEK Q02763 1/20 0.51
▸ RIPK1 Q13546 3/20 0.48
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ RAF1 P04049 1/20 0.46
▸ KDR P35968 9/20 0.45
▸ PDGFRA P16234 2/20 0.45
▸ KIT P10721 1/20 0.45
▸ CDK8 P49336 1/20 0.43
▸ BRAF P15056 2/20 0.43
▸ BTK Q06187 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ TNNI3K Q59H18 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP3A5 P20815 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13459937 0.84 RIPK1 (0.48) RIPK1KDRPDGFRAKITCYP3A4
SCHEMBL13459528 0.83 FLT1 (0.54) FLT1TEKRIPK1CA12CA1
SCHEMBL13459835 0.77 RIPK1 (0.75) TEKRIPK1KDRBRAF
SCHEMBL22588908 0.74 CA12 (0.72) CA12CA1CA2CA9RAF1
SCHEMBL1492839 0.74 PORCN (0.61) FLT1TEKCA12CA1CA2
SCHEMBL13459571 0.72 IMPDH2 (0.51) CA12CA1CA2CA9RAF1
SCHEMBL1334315 0.71 KDR (0.79) FLT1KDR
SCHEMBL21295354 0.71 MAPT (0.72) CA12CA1CA2CA9RAF1
SCHEMBL3529742 0.71 KDR (0.79) FLT1TEKKDRKIT
Hydrochloric Acid SCHEMBL7657613 0.70 HTR2C (0.57) FLT1CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010032986-A2 NOVEL 5-(4-AMINOPHENYL)-ISOQUINOLINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PRODUCTION METHOD FOR SAME, AND COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PROPHYLAXIS AND TREATMENT OF MEDICAL CONDITION INDUCED BY RAF KINASE HYPERACTIVITY 주식회사 이큐스팜 (KR) 2010-03-25 — — WO disclosed
Send feedback